| 1RY0 | A:; B: | STRUCTURE OF PROSTAGLANDIN F SYNTHASE WITH PROSTAGLANDIN D2 |
| 1RY8 | A:; B: | PROSTAGLANDIN F SYNTHASE COMPLEXED WITH NADPH AND RUTIN |
| 1S1P | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1S1R | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1S2A | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1S2C | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1XF0 | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) COMPLEXED WITH DELTA4-ANDROSTENE-3,17-DIONE AND NADP |
| 1ZQ5 | A: | CRYSTAL STRUCTURE OF HUMAN ANDROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEXED WITH A POTENT INHIBITOR EM1404 |
| 2F38 | A: | CRYSTAL STRUCTURE OF PROSTAGLANDIN F SYNATHASE CONTAINING BIMATOPROST |
| 2FGB | A: | CRYSTAL STRUCTURE OF HUMAN 17BET A-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEXES WITH PEG AND NADP |
| 3R43 | A: | AKR1C3 COMPLEXED WITH MEFENAMIC ACID |
| 3R58 | A: | AKR1C3 COMPLEX WITH NAPROXEN |
| 3R6I | A: | AKR1C3 COMPLEX WITH MECLOFENAMIC ACID |
| 3R7M | A: | AKR1C3 COMPLEX WITH SULINDAC |
| 3R8G | A: | AKR1C3 COMPLEX WITH IBUPROFEN |
| 3R8H | A: | AKR1C3 COMPLEX WITH ZOMEPIRAC |
| 3R94 | A: | AKR1C3 COMPLEX WITH FLURBIPROFEN |
| 3UFY | A: | AKR1C3 COMPLEX WITH R-NAPROXEN |
| 3UG8 | A: | AKR1C3 COMPLEX WITH INDOMETHACIN AT PH 7.5 |
| 3UGR | A: | AKR1C3 COMPLEX WITH INDOMETHACIN AT PH 6.8 |
| 3UWE | A: | AKR1C3 COMPLEXED WITH 3-PHENOXYBENZOIC ACID |
| 4DBS | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 3'-[(4-NITRONAPHTHALEN-1-YL) AMINO]BENZOIC ACID |
| 4DBU | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 3-((4 -(TRIFLUOROMETHYL)PHENYL) AMINO)BENZOIC ACID |
| 4DBW | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 2'-DESMETHYL-INDOMETHACIN |
| 4DZ5 | A: | W227F ACTIVE SITE MUTANT OF AKR1C3 |
| 4FA3 | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH (R)-1-(NAPHTHALEN-2-YLSULFONYL)PIPERIDINE-3-CARBOXYLIC ACID (86) |
| 4FAL | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH 3-((3,4-DIHYDROISOQUINOLIN-2(1H)-YL)SULFONYL)-N-METHYLBENZAMIDE (80) |
| 4FAM | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH 3-((3,4-DIHYDROISOQUINOLIN-2(1H)-YL)SULFONYL)BENZOIC ACID (17) |
| 4H7C | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH 1-{4-[(2-METHYL-1-PIPERIDINYL)SULFONYL]PHENYL}-2-PYRROLIDINONE |
| 4HMN | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH (4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)(MORPHOLINO) METHANONE (24) |
)
)